We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
226
O'Reilly Automotive
ORLY
$76.2B
$2.64M 0.07%
69,975
-62,340
-47% -$2.24M
CLF icon
227
Cleveland-Cliffs
CLF
$6.98B
$2.63M 0.07%
122,242
+49,677
+68% +$979K
MASI
228
DELISTED
Masimo
MASI
$2.63M 0.07%
10,867
+3,872
+55% +$883K
NVCR icon
229
NovoCure
NVCR
$1.83B
$2.63M 0.07%
11,854
+5,494
+86% +$1.07M
ARKG icon
230
ARK Genomic Revolution ETF
ARKG
$1.63B
$2.61M 0.07%
+28,220
New +$2.4M
SIZE icon
231
iShares MSCI USA Size Factor ETF
SIZE
$438M
$2.61M 0.07%
20,138
+19,602
+3,657% +$2.47M
REG icon
232
Regency Centers
REG
$14.1B
$2.6M 0.07%
40,627
+8,697
+27% +$550K
MS icon
233
Morgan Stanley
MS
$336B
$2.6M 0.07%
28,348
-175,978
-86% -$15.1M
PFGC icon
234
Performance Food Group
PFGC
$18B
$2.59M 0.07%
53,485
+41,090
+332% +$2.17M
SOFI icon
235
SoFi Technologies
SOFI
$23.4B
$2.57M 0.07%
133,931
+133,830
+132,505% +$2.48M
NUAN
236
DELISTED
Nuance Communications, Inc.
NUAN
$2.56M 0.07%
47,114
+32,718
+227% +$1.72M
SPXU icon
237
ProShares UltraPro Short S&P 500
SPXU
$396M
$2.55M 0.07%
6,990
+248
+4% +$99.3K
VTRS icon
238
Viatris
VTRS
$19B
$2.55M 0.07%
178,164
+83,490
+88% +$1.21M
SBIO icon
239
ALPS Medical Breakthroughs ETF
SBIO
$213M
$2.54M 0.07%
51,955
+39,956
+333% +$1.91M
BSX icon
240
Boston Scientific
BSX
$71.4B
$2.54M 0.07%
59,357
-81,716
-58% -$3.44M
DAR icon
241
Darling Ingredients
DAR
$9.62B
$2.53M 0.07%
37,453
+17,305
+86% +$1.22M
UVXY icon
242
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
$2.53M 0.07%
361
+143
+66% +$1.47M
ETR icon
243
Entergy
ETR
$49.7B
$2.51M 0.07%
50,382
-2,744
-5% -$145K
MMTM icon
244
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$162M
$2.51M 0.07%
13,828
+13,795
+41,803% +$2.43M
CSGP icon
245
CoStar Group
CSGP
$12B
$2.5M 0.07%
30,184
-6,006
-17% -$519K
REGN icon
246
Regeneron Pharmaceuticals
REGN
$79.5B
$2.5M 0.07%
4,473
-11,412
-72% -$5.78M
NTES icon
247
NetEase
NTES
$83.5B
$2.48M 0.06%
21,516
+424
+2% +$46.7K
EXPE icon
248
Expedia Group
EXPE
$36.8B
$2.47M 0.06%
15,099
+2,795
+23% +$479K
CACI icon
249
CACI
CACI
$13.9B
$2.45M 0.06%
9,611
-7,914
-45% -$2.04M
IWB icon
250
iShares Russell 1000 ETF
IWB
$49.7B
$2.45M 0.06%
10,123
-3,641
-26% -$858K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.